Project Management Institute Announces List of 50 Next Generation Leaders to Watch
Project Management Institute (PMI) today announced its first annual Future 50 list, which features the 50 next generation leaders that are creating, building, and transforming the world through notable projects. The 50 young standout project leaders highlighted in the specially dedicated July/August issue of PM Network® magazine represent the wave of change and talent around the globe—a youthquake that will reshape the future and accelerate innovation in the here and now. Honorees include groundbreaking achievements from people across a variety of industries and countries, including Director Greta Gerwig, Laura Jones from the Special Olympics and Miishe Addy from Jetstream Africa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200713005075/en/
According to PMI’s recent Pulse of the Profession ® report, only 40 percent of organizations say they prioritize attracting and hiring the young generation of project professionals. But what the Future 50 list highlights is that this next generation will be crucial to driving value for businesses and society now and in the future.
“As a new generation of leaders rise around the world we are seeing them have additional guiding principles and motivations when compared to earlier generations. Organizations are already rethinking how they can attract, retain and help foster this generation of talent,” said Sunil Prashara, President and CEO of Project Management Institute. “This next generation of project leaders are deeply committed to driving change across the world – from having a deep sense of social responsibility and improving the environment to driving diversity and inclusion. The 50 individuals featured on this list are some of the biggest change makers of their generation. They exemplify the power and transformative change that can happen through projects.”
As part of the July/August issue of PM Network, PMI interviewed this year’s Future 50 winners and other seasoned professionals around the globe to uncover ways to encourage this next generation of talent. The issue also outlines six rules to harness the power of these future-focused professionals, including igniting a learning culture; picking up the pace of development; a flatter, more communicative leadership team; more purpose-driven work; and constant, iterative feedback.
To identify this year’s Future 50 honorees, PMI reached out to hundreds of experts and stakeholders across the globe for nominations. A special committee vetted the rising project professionals and narrowed the options. Finalists were then individually researched and/or interviewed to create a list that represents the full spectrum of regions, industries and achievements in The Project Economy – where work increasingly centers around executing projects both large and small. While some honorees are Project Management Professional (PMP)® credential holders, others would not even describe themselves as project managers. What unites the Future 50 is a commitment to project work as the foundation of positive impact, for today and tomorrow.
To learn more about the complete list of honorees and the rules to drive this next generation of talent, visit PMI.org/Future50.
The 50 Future Leaders to Watch:*
- Abdullah Seflan, Saudi Aramco
- Ada Osakwe, Qantas
- Adam Fahrenkopf, Google
- Alagesan Hanippuya, RHB Banking Group
- Andrew Walters, National Australia Bank
- Arman Köklü, GE
- Bilel Manai, Al Bawsala
- Boyan Slat, The Ocean Cleanup
- Rep. Bryan Steil, United States House of Representatives
- Charlyn Johnson, UK Ministry of Justice
- Diletta Invernizzi, Jacobs
- Gabriel Costa Caldas, Alpha Ports
- Geetha Gopal, Panasonic
- Gillian Dowds, BAE Systems Maritime
- Gregory Daniels, Zoom
- Greta Gerwig, Director
- Greta Thunberg, Climate Change Activist
- Hayden Brown, Upwork
- Janeen Blige, IBM
- Jaspreet Dol, DXC
- Jenk Oz, Thred
- Jia Song, Didi
- Jonathan Kadishson, Burns & McDonnell
- Julissa Mateo Abad, Bunker
- Kamil Mroz, UCB
- Kaspar Korjus, PactumAI
- Katerina Treppeschova, Facebook
- Kenneth Harris II, NASA
- Laura Jones, Special Olympics
- Leanne Pittsford, Include.io/Lesbians Who Tech
- Lijuan Gao, NICE
- Marina Tranchitella, Sport Club Internacional
- Miishe Addy, Jetstream Africa
- Pascale Sablan, S9 Architecure
- Rajesh Kumar Nalla, Techimax IT
- Prime Minster Sanna Marin, Government of Finland
- Sevi Rich, BHP
- Sitanshu Dash, Adobe
- Stephen Xu, Alibaba
- Taiwo Abraham, Horizant
- Tamara Kotevska, Documentary Producer
- Tiago Chavez Oliveira, Government of Brazil
- Tim Kaltwasser, Airbus
- Vidhya Abhjith, Codewave Tech
- Vihari Kanukollu, UrbanKisaan
- Wanja Murekio, Safaricom
- Whitney Wolfe Herd, Bumble
- Ye Fei, ZTE
- Yingjin Liu, DSM
- Yoftahe Yohannes, Ericsson
*All product names, logos, and brands are the property of their respective owners
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com www.facebook.com/PMInstitute and on Twitter @PMInstitute.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200713005075/en/
Contact information
Rachael Ballard, 443-618-7014
rachael.ballard@pmi.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 10:05:00 EET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge ® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 10:00:00 EET | Press release
Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support commercial manufacturing of Omisirge® for this additional indication at its state-of-the-art cGMP cell therapy manufacturing facility in Hopkinton, MA. “We are excited to expand our collaboration with RoslinCT to add US manufacturing as Omisirge® moves into its next phase with the recent FDA approval for patients suffering from severe apl
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 08:00:00 EET | Press release
Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It proves a supplier has undergone an exhaustive audit of its governance, security controls, and operational processes. For Dutch financial institutions, this qualificatio
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 04:00:00 EET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 03:00:00 EET | Press release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom